(NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals ...

Proteins form the structural and functional backbone of the cell, and any perturbation in their synthesis can disrupt normal ...

Using cell-free protein synthesis, digital microfluidics, and optimized additive screening, eProtein Discovery can express ...

School of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China ...

Pathogenic Salmonella injects effector proteins into the cells of the gastrointestinal tract to penetrate and multiply within them. The bacteria are usually ingested with contaminated food. They ...

Nuclera, a Cambridge biotech accelerating protein expression and optimisation, has added a new membrane protein workflow to its benchtop eProtein Discovery™ system.

Using cell-free protein synthesis, digital microfluidics, and optimized additive screening, eProtein Discovery can express and purify functional, correctly folded membrane proteins, in 48 hours.

A deficiency in mitochondrial protein synthesis, due to the knockout of the MTO1 gene in hematopoietic cells, disrupts intracellular iron distribution, leading to fetal anemia.

Sutro Biopharma, Inc.’s STRO share price has dipped by 15.38%, which has investors questioning if this is right time to buy.